Barclays PLC Oric Pharmaceuticals, Inc. Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Barclays PLC holds 107,261 shares of ORIC stock, worth $884,903. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107,261
Previous 107,261
-0.0%
Holding current value
$884,903
Previous $1.1 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ORIC
# of Institutions
124Shares Held
66.6MCall Options Held
7.8KPut Options Held
700-
Nextech Invest Ag5.29MShares$43.6 Million8.84% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$39.9 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$36.3 Million4.67% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$34.2 Million2.29% of portfolio
-
Viking Global Investors LP4MShares$33 Million0.16% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $327M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...